European Union nations sign deal for coronavirus vaccine

European Union nations sign deal for coronavirus vaccine

European Union nations sign deal for coronavirus vaccine

'The company is seeking to expand manufacturing capacity further and is open to collaborating with other companies in order to meet its commitment to support access to the vaccine at no profit during the pandemic, ' the drugs manufacturer said.

Deliveries will start by the end of 2020.

The deal is the first contract signed by Europe's Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as possible.

"We have leveraged the Institute's expertise and infrastructure to be able to compress what would, under normal circumstances, be two years of discovery and design work into several months", said Dr. Kayvon Modjarrad, director of the emerging infectious disease branch of the Walter Reed Army Institute of Research.

The vaccine was developed by Oxford University's Jenner Institute, working with the Oxford Vaccine Group.

Soriot told reporters Saturday that conversations were also under way with the governments of many other nations, including Japan, Russia and Brazil.

Moderna Therapeutics has announced that its COVID-19 vaccine is set to go into the third and final stage of clinical human trials.

"Many countries in the world have already secured vaccines, Europe has not yet", German Health Minister Jens Spahn said.

AstraZeneca has agreed manufacturing deals globally to meet its target of producing 2 billion doses of the vaccine, including with two ventures backed by Bill Gates and a US$1.2 billion (RM5.1 billion) agreement with the U.S. government. The agreement with AstraZeneca also aims to make the vaccine available to other European countries that wish to take part.

The European Commission on Friday spoke out in favor of advance purchase contracts, after the EU governing body received a mandate from EU governments to make such purchases itself.

Other companies, including USA biotech company Moderna and French pharmaceutical company Sanofi, are pursuing the creation of a coronavirus vaccine - which is the only possible way to return safely to "normal life" in the post-COVID-19 world.

Related news



[an error occurred while processing the directive]